Skip to main content
SpringerLink
Log in

Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas

  • Published:
Virchows Archiv A Aims and scope Submit manuscript

Summary

The present study deals with qualitative und quantitative analysis of osteoclastic bone resorption in metastatic bone disease. 267 cases were examined histomorphologically and divided into three developmental stages. In the first ‘phase of early appearance’ no bone resorption takes place. The stimulation of osteoclastic resorption in the surroundings of tumour tissue is typical in the second ‘phase of interaction’. Pressure atrophy, aseptic necrosis and osteolysis by the tumour cells themselves are other mechanisms of bone destruction in the last ‘phase of carcinomatosis’. Because osteoclasts are exclusively responsible for the loss of bone tissue in the ‘phase of interaction’, this stage is suited for precise quantitative analysis of osteoclastic resorption. 24 pure osteolytic secondary bone tumours of various primary lesions were examined histomorphometrically. The numerical values were compared with each other and with standard values of healthy individuals. In contrast with normal bone tissue the fractional resorption surfaces und osteoclast indices increase in metastases. Activated osteoclasts are larger and have more nuclei. The numbers of osteoclast index and nuclei per osteoclast are significantly higher in renal than in breast carcinoma. Osteoclasts can be activated in distances of more than 500 µm from tumour tissue. The mean stimulation distance in metastasis from squamous cell carcinoma is markedly higher than in secondary bone tumours of breast carcinoma. Several osteoclast activating substances and divers mechanisms of stimulation might be responsible for different numerical values of morphometric parameters in metastases from various primary malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Baron R (1977) Importance of intermediate phase between resorption and formation in the measurement and unterstanding of the bone remodeling sequence. In: Meunier PJ (ed) Bone histomorphometry, second international workshop. Toulouse, France: Société de la Nouvelle Imprimerie Fournie, pp 179–183

    Google Scholar 

  • Bennet A, Simpson JS, Mc Donald AM, Stamford IF (1975) Breast cancer, prostaglandins and bone metastases. Lancet 31:1218–1220

    Google Scholar 

  • Binstock ML, Mundy GR (1980) Effect of calcitonin and glucocorticoids in combination on hypercalcemia of malignancy. Ann Int Med 93:269–272

    Google Scholar 

  • Bonucci E (1981) New knowledge on the origin, function and fate of osteoclasts. Clin Orthop 158:252–269

    Google Scholar 

  • Bringhurst FR, Vorner V, Segre GV (1982) Cancer associated hypercalcemia: Characterization of a new bone resorbing factor. Clin Res 30/2:386A

    Google Scholar 

  • Caro JF, Beserab A, Flymn JT (1979) Prostaglandin E and hypercalcemia in breast carcinoma: only a tumour marker? Am J Med 66:337–341

    Google Scholar 

  • Chambers TJ (1980) The cellular basis of bone resorption. Clinical Orthop Rel Res 151:283–293

    Google Scholar 

  • Chambers TJ, Dunn CJ (1982) The effect of parathroid hormone, 1,25 dihydroxycholecalciferol and prostaglandins on the cytoplasmatic activity of isolated osteoclasts. J Path 137:193–203

    Google Scholar 

  • Chambers TJ, Path MRC (1980) The cellular basis of bone resorption. Clin Orthop Rel Res 151:283–293

    Google Scholar 

  • Cramer SF, Fried L, Carter KJ (1981) The cellular basis of metastatic bone disease in patients with lung cancer. Cancer 48:2649–4660

    Google Scholar 

  • Delling G (1972) Über eine vereinfachte Methacrylateinbettung für unentkalkte Knochenschnitte. Beitr Pathol 145:100–105

    Google Scholar 

  • Delling G (1975) Endocrine Osteopathien. Morphologie, Histomorphometrie, Differentialdiagnose. Veröffentlichungen aus der Pathologie. Heft 98. Stuttgart: Gustav Fischer Verlag

    Google Scholar 

  • Delling G (1979) Morphometrie des Knochengewebes. Dtsch Ges Innere Med 229–239

  • Delling G, Luehmann H, Baron R, Mathews CHE, Olah A (1981) Investigation of intra-reader retroducibility. In: Jee WSS, Parfitt M (eds). Bone Histomorphometry, Third International Workshop. Paris: Société Nouvelle de Publications Médicales et Deutaires. 419–427

    Google Scholar 

  • De Maria D, Mandolini G, Falchi AM, Balli M (1979) La calcitonina nel Trattamento di Pazienti con Metastasi ossee da carcinoma mammario: Esperienze chliniche in calcitonina: nuove asquisizioni e prospettive. In: De Bastiani G, Pecile A, Pietrograde V, Sirtori C (eds) Fondazione Carlo Erba, Milano

    Google Scholar 

  • Eilon G, Mundy GR (1979) Increase in cyclic AMP in human brest cancer cells causes release of hydrolytic encymes and bone resorbing activity. Presented at first annual meeting of the American Society for Bone and Mineral Research. Anaheim, California

  • Elomaa I, Blomquist C, Porkka L (1984) Supportive clodrante therapy for bone metastasis, a follow-up period. Calcif Tissue [Suppl] 36/2:28

    Google Scholar 

  • Fleisch H, Felix R (1979) Diphosphonates. Calcif Tissue Res 27:91–94

    Google Scholar 

  • Frost HM (1963) Bone remodeling dynamics. Thomas, Springfield, Illinois

    Google Scholar 

  • Frost HM (1977) A method of analysis of trabecular bone dynamics. In: Meunier PJ, Bone histomorphometry. Second International Workshop, Toulouse, France: Société de la Nouvelle Imprimerie Fournie, pp 445–476

    Google Scholar 

  • Galasko CSB, Bennet A (1976) Relationship of bone destruction in skeletal metastasis to osteoclast activation and protaglandins. Nature 263:508–510

    Google Scholar 

  • Galasko CSB, Samuel AW, Rushton S, Lacey E (1980) The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour induced osteolysis. Br J Surg 67:493–496

    Google Scholar 

  • Galasko CSB (1981) The development of skeletal metastases. In: Weiss LW, Gilbert HA (eds) Bone metastasis. Hall GK, Medical Publ, Boston, pp 49–63

    Google Scholar 

  • Gordan GS, Roof BS, Halden A (1973) Skeletal effects of cancer and their management. In: Holland JF, Frei E (eds) Lea and Febinger. Cancer Medicine, Philadelphia, pp 1073–1083

    Google Scholar 

  • Hasling C, Charles P, Mosekilde L (1984) Intravenous EHDP for treatment of hypercalcemia of malignancy. Calcif Tissue [Suppl 36] 2:28

    Google Scholar 

  • Jee WSS, Kimmel DB (1977) Bone cell origin at the endosteal surface. In: Meunier PJ. Bone Histomorphometry. Second International Workshop. Toulouse, France: Societe de la Nouvelle Imprimerie Fournie, pp 113–131

    Google Scholar 

  • Jung A, Mermillod B, Barras C, Baud M, Courvoisier (1981) Inhibition by two diphosphonates for treating malignant hypercalcemia. Cancer 48:1922–1925

    Google Scholar 

  • Jung A (1983) Inhibition of tumour induced osteolysis. In: Stoll BA, Parbhoo S (eds) Bone Metastasis: Monitoring and Treatment. Raven Press, New York, pp 47–57

    Google Scholar 

  • Koeffler HP, Mundy GR, Golde DW, Cline MJ (1978) Production of tumour resorbing activity in poorly differentiated monocytic malignancy. Cancer 41:2438

    Google Scholar 

  • Kulenkampff H-A, Delling G (1984) Die Stimulation der osteoclastaeren Osteolyse bei Knochenmetastasen- eine quantitative Untersuchung. Verh Dtsch Ges Pathol 68:518

    Google Scholar 

  • Merz WA (1967) Die Streckenmessung an gerichteten Strukturen im Mikroskop und ihre Anwendung zur Bestimmung von Oberflächen-Volumen-Relationen im Knochengewebe. Mikroskopie 22:132–142

    Google Scholar 

  • Milch RA, Changus GW (1956) Response of bone to tumour invasion. Cancer 9:341–351

    Google Scholar 

  • Mundy GR, Luben RA, Raisz LG, Oppenheim JJ, Buell DN (1974) Bone resorbing activity in supernatants from lymphoid cell lines. N Engl J Med 290:867–871

    Google Scholar 

  • Mundy GR, Raisz LG, Cooper RA, Schechter GP, Salmon SE (1974) Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 291:1041–1046

    Google Scholar 

  • Mundy GR, Raisz LG (1977) Big and little forms of osteoclast activating factor. J Clin Invest 60:122–128

    Google Scholar 

  • Mundy GR, Ibbotson KJ, D'Souza SM (1984) Bone and cancer. Calcif Tiss (Sup) 36/2:25

    Google Scholar 

  • Omenn GS, Roth SI, Baker WH (1969) Hyperparathyroidism associated with malignant tumour of non-parathyroid origin. Cancer 24:1004–1012

    Google Scholar 

  • Perlia CP, Gubisch NJ, Wolter J, Edelberg D, Deterich MM, Taylor III SG (1970) Mithramycin treatment of hypercalcemia. Cancer 25:389–394

    Google Scholar 

  • Powles TJ, Dowsett M, Easty GC, Easty DM, Neville AM (1976) Breast cancer osteolysis bone metastases and anti-osteolytic effect of aspirin. Lancet 1:608–610

    Google Scholar 

  • Raisz LG, Luben RA, Mundy GR, Dietrich JW, Horton JE, Trummel CL (1975) Effect of osteoclast activating factor from human leucocytes on bone metabolism. J Clin Invest 56:408–413

    Google Scholar 

  • Raisz LG, Yahing CH, Bock RS, Bower BF (1979) Comparison of commercially available parathyroid hormone immunassys in the differential diagnosis of hypercalcemia due to primary hyperparathyreoidism of malignancy. Ann Int Med 91:739–740

    Google Scholar 

  • Rodan GA, Martin TJ (1981) Role of osteoblasts in humoral control of bone resorption- a hypothesis. Calcif Tissue Int 33:349–351

    Google Scholar 

  • Scherwood LM, O'Riordan JLM, Aurbach GM, Potts FT jr (1967) Production of parathyroid hormone by non parathyroid tumours. J Clin Endocrinol 27:140–146

    Google Scholar 

  • Seyberth HW, Segre GV, Morgan JL, Sweetman BJ, Potts JT jr, Oates JA (1975) Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med 293:1278–1283

    Google Scholar 

  • Simpson El, Mundy GR, D'Souza SM, Ibbotson KJ, Bockman R, Jacobs JW (1983) Absence of parathyroid hormone messenger RNA in nonparathyroid tumours associated with hypercalcemia. N Engl J Med 309/6:325–330

    Google Scholar 

  • Stamp TCB, Child JA, Walker PG (1975) Treatment of osteolytic myolysis with mithramycin. Lancet 29:719–722

    Google Scholar 

  • Tashjian AH (1978) Role of prostaglandins in the production of hypercalcemia by tumours. Cancer Res 38:4138–4143

    Google Scholar 

  • Tashjian AH jr, Levine L (1978) Epidermal growth factor stimulates prostaglandin production and bone resorption in cultured mouse calvaria. Biochem Biophys Res Commun 85:966–975

    Google Scholar 

  • Todaro GJ, Fryling C, De Larco JE (1980) Transforming growth factors produced by certain human tumour cells, polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci (USA) 77:5258–5262

    Google Scholar 

  • Trump DL (1983) Mechanisms of bone destruction by cancer. In: Stoll BA, Parbhoo S (eds) Bone Metastasis: Monitoring and Treatment. Raven Press, New York, pp 39–46

    Google Scholar 

  • Voekel EF, Tashjian AH jr, Franklin R, Wasserman E, Levine L (1975) Hypercalcemia and tumour prostaglandins: The VX-2 carcinoma model in rabbit. Metabolism 24:937–986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathology, University of Hamburg, Martinistrasse 52, D-2000, Hamburg, Federal Republic of Germany

    H. -Albrecht Kulenkampff, Thomas Dreyer, Wilhelm Kersjes & Günter Delling

Authors
  1. H. -Albrecht Kulenkampff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Dreyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wilhelm Kersjes
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Günter Delling
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dedicated to Prof. Dr. G. Seifert on the occasion of his 65th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kulenkampff, H.A., Dreyer, T., Kersjes, W. et al. Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas. Vichows Archiv A Pathol Anat 409, 817–828 (1986). https://doi.org/10.1007/BF00710766

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00710766

Key words

Search

Navigation